絞り込み

16501

広告

Treatment dynamics of bone-targeting agents among men with bone metastases from prostate cancer in the United States.

著者 Butler AM , Cetin K , Hernandez RK , Diane Reams B , Overman RA , I Kim J , Hirsch BR , Abernethy AP , Liede A , Alan Brookhart M
Pharmacoepidemiol Drug Saf.2018 Jan 07 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (27view , 0users)

Full Text Sources

To examine the dynamics of treatment with 2 bone-targeting agents (BTAs)-denosumab and zoledronic acid-among men with bone metastases from prostate cancer.
PMID: 29316026 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード